Word

PARCLYA

Status

Pending

Status Code

731

Status Date

Monday, September 9, 2024

Serial Number

97662905

Mark Type

4

Filing Date

Saturday, November 5, 2022

Published for Opposition

Tuesday, July 18, 2023

Trademark Owner History

Novartis AG - Owner At Publication

Classifications

5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; all of the above excluding contraceptives

The wording PARCLYA has no meaning in a foreign language.

Trademark Events

Nov 9, 2022

New Application Entered

Nov 22, 2022

New Application Office Supplied Data Entered

Jun 12, 2023

Assigned To Examiner

Jun 15, 2023

Approved For Pub - Principal Register

Jun 28, 2023

Notification Of Notice Of Publication E-Mailed

Jul 18, 2023

Published For Opposition

Jul 18, 2023

Official Gazette Publication Confirmation E-Mailed

Sep 12, 2023

Noa E-Mailed - Sou Required From Applicant

Mar 8, 2024

Sou Teas Extension Received

Sep 9, 2024

Sou Teas Extension Received

Sep 9, 2024

Notice Of Approval Of Extension Request E-Mailed

Sep 9, 2024

Sou Extension 2 Filed

Sep 9, 2024

Sou Extension 2 Granted

Mar 9, 2024

Notice Of Approval Of Extension Request E-Mailed

Mar 8, 2024

Sou Extension 1 Filed

Mar 8, 2024

Sou Extension 1 Granted